Skip to content

Author

Oktavia Suryani

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Studi In Silico Molekuler Turunan Kumarin sebagai Kandidat Inhibitor ER-α pada Antikanker Payudara

Cancer is one of the leading causes of death worldwide, prompting the development of new candidate therapeutic agents. Coumarin derivatives have potential anticancer activity, but their pharmacokinetic characteristics, toxicity, and binding affinity for the target receptor require evaluation. This study aims to evaluat...

L. Wardani, Oktavia Suryani · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.